NFKB1 and tuberculosis: Another anti-inflammatory agent, thalidomide, can also block NF-κB activation through inhibition of IKK (Keifer et al, 2001), and has been shown to promote weight gain in HIV-infected patients receiving treatment for tuberculosis (Reys-Teran et al, 1996), and is currently under evaluation for the treatment of cancer cachexia.